Xenon Pharmaceuticals, Inc. (XENE)
56.00
-2.59
(-4.42%)
USD |
NASDAQ |
May 07, 16:00
56.50
+0.50
(+0.89%)
Pre-Market: 08:28
Xenon Pharmaceuticals Research and Development Expense (Annual) : 298.40M for Dec. 31, 2025
Research and Development Expense (Annual) Chart
Sep '18
Jan '19
May '19
285.00
270.00
255.00
240.00
Historical Data
R&D Expense Definition
R&D expense is a line item from many companies' income statements.
Research and Development Expense (Annual) Range, Past 5 Years
--
Minimum
--
Maximum
--
Average
--
Median
Research and Development Expense (Annual) Benchmarks
| Aurinia Pharmaceuticals, Inc. | 32.50M |
| Edesa Biotech, Inc. | 3.669M |
| Lexaria Bioscience Corp. | 8.239M |
| Sirona Biochem Corp. | -- |
| ProMIS Neurosciences, Inc. | 33.38M |